Angus Thomson and colleagues describe the consequences of mammalian target of rapamycin (mTOR) inhibition by rapamycin on dendritic cells, effector T cells and regulatory T cells. These effects make mTOR inhibition a promising immunosuppressive, but tolerance-promoting, therapeutic strategy.
- Angus W. Thomson
- Hēth R. Turnquist
- Giorgio Raimondi